Balaxi Pharmaceuticals Market Cap ($13.99M USD)
Balaxi Pharmaceuticals Market Cap ($13.99M USD). As of Oct. 6, 2026, Balaxi Pharmaceuticals (BALAXI) market capitalisation is ₹125.87 Cr ($13.99M), with 5.55 Cr shares outstanding at a current price of ₹22.67 on NSE, ranking 2938 out of 5368 companies by market cap in our screener. Balaxi Pharmaceuticals operates in the Healthcare sector and is classified as a Small Cap stock. Compare with BALAXI stock valuation models to assess whether the stock is under or overvalued.
Market Cap History of Balaxi Pharmaceuticals (Last 10 Years)
BALAXI market capitalisation from year-end NSE closing prices over the last 10 years. Examine Balaxi Pharmaceuticals quarterly financials for recent quarterly revenue, profit and EPS trends.
End of Year Market Cap History — Balaxi Pharmaceuticals
BALAXI year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see BALAXI share price.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹125.87 Cr
$13.99M USD
|
₹22.67 | NSE | -15.63% |
| 2025 |
₹149.19 Cr
$16.58M USD
|
₹26.87 | NSE | -62.84% |
| 2024 |
₹401.48 Cr
$44.61M USD
|
₹72.31 | NSE | -16.36% |
| 2023 |
₹479.99 Cr
$53.33M USD
|
₹86.45 | NSE | -28.82% |
| 2022 |
₹674.32 Cr
$74.92M USD
|
₹121.45 | NSE | +18.37% |
| 2021 |
₹569.66 Cr
$63.30M USD
|
₹102.60 | NSE | -21.08% |
| 2020 |
₹721.80 Cr
$80.20M USD
|
₹130.00 | NSE | +700.00% |
| 2019 |
₹90.22 Cr
$10.02M USD
|
₹16.25 | NSE | +185.09% |
| 2018 |
₹31.65 Cr
$3.52M USD
|
₹5.70 | NSE | +93.22% |
| 2017 |
₹16.38 Cr
$1.82M USD
|
₹2.95 | NSE | -13.24% |
| 2016 |
₹18.88 Cr
$2.10M USD
|
₹3.40 | NSE | -33.98% |
| 2015 |
₹28.59 Cr
$3.18M USD
|
₹5.15 | NSE | - |